Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Polygenic scores for psychiatric disorders in a diverse postmortem brain tissue cohort
    Published on 2023-01-23
    3 years ago
  • Neuronal and astrocytic CB1R signaling differentially modulates goal-directed behavior and working memory by distinct temporal mechanisms
    Published on 2023-01-23
    3 years ago
  • Chronic escitalopram in healthy volunteers has specific effects on reinforcement sensitivity: a double-blind, placebo-controlled semi-randomised study
    Published on 2023-01-22
    3 years ago
  • IN MEMORIAM Ghanshyam Narayan Pandey 1937–2022
    Published on 2023-01-22
    3 years ago
  • Cholinergic system adaptations are associated with cognitive function in people recently abstinent from smoking: a (-)-[18F]flubatine PET study
    Published on 2023-01-20
    3 years ago
  • Chronic MAP4343 reverses escalated alcohol drinking in a mouse model of alcohol use disorder
    Published on 2023-01-19
    3 years ago
  • To dismantle structural racism in science, scientists need to learn how it works
    Published on 2023-01-15
    3 years ago
« Previous 1 … 129 130 131 132 133 … 143 Next »
Journal of Psychopharmacology
  • Therapeutic potential and underlying mechanism of sarcosine (N-methylglycine) in N-methyl-D-aspartate (NMDA) receptor hypofunction models of schizophrenia
    Published on 2019-07-11
    7 years ago
  • Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
    Published on 2019-07-11
    7 years ago
  • Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model
    Published on 2019-07-10
    7 years ago
  • Differential rewarding effects of electrical stimulation of the lateral hypothalamus and parabrachial complex: Functional characterization and the relevance of opioid systems and dopamine
    Published on 2019-07-08
    7 years ago
  • A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia
    Published on 2019-07-02
    7 years ago
  • Brain circuitry, behavior, and cognition: A randomized placebo-controlled trial of donepezil in fragile X syndrome
    Published on 2019-07-02
    7 years ago
  • Resting-state dynamics as a neuromarker of dopamine administration in healthy female adults
    Published on 2019-06-27
    7 years ago
« Previous 1 … 129 130 131 132 133 … 145 Next »
European Neuropsychopharmacology
  • P.856Evidence-based psychoeducational program in first psychotic episode patients
    Published on 2020-11-25
    6 years ago
  • P.831Trajectories of suicidal ideation after a first-episode psychosis: a growth mixture modeling approach
    Published on 2020-11-25
    6 years ago
  • P.857Cognitive reserve in child and adolescent offspring of patients diagnosed with schizophrenia or bipolar disorder
    Published on 2020-11-25
    6 years ago
  • P.832DRD1 protein and mRNA levels in peripheral blood lymphocytes: influence of SNPs of 5′-untranslated region and the schizophrenia disorder
    Published on 2020-11-25
    6 years ago
  • P.740 Mechanistic basis behind the antidepressant response of ketamine and hydroxynorketamine (HNK)
    Published on 2020-11-25
    6 years ago
  • P.834Hyperactivated brain response to fear and disgust in schizophrenia
    Published on 2020-11-25
    6 years ago
  • P.836Metabolic syndrome and long-acting injected (LAI) preparations in schizophrenia: a “real-world” study
    Published on 2020-11-25
    6 years ago
« Previous 1 … 129 130 131 132 133 … 166 Next »

   Pharma Pub